Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study

AIM: To evaluate (I) trastuzumab-containing primary systemic therapy (PST) in human epidermal growth factor receptor 2 (Her2) overexpressing breast carcinomas; (II) compare the patients who achieved and those who did not achieve pathological complete remission (pCR), and (III) analyze the accuracy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tőkés, Tímea, Szentmártoni, Gyöngyvér, Torgyík, László, Kajáry, Kornélia, Lengyel, Zsolt, Györke, Tamás, Molnár, Béla Á., Tőkés, Anna-Mária, Kulka, Janina, Dank, Magdolna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2015
Materias:
RECOOP for Common Mechanisms of Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410165/
https://www.ncbi.nlm.nih.gov/pubmed/25891872
http://dx.doi.org/10.3325/cmj.2015.56.128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410165/
https://www.ncbi.nlm.nih.gov/pubmed/25891872
http://dx.doi.org/10.3325/cmj.2015.56.128

Ejemplares similares